Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920)
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1038/s41598-019-53755-5 http://hdl.handle.net/11449/198181 |
Resumo: | The World Health Organization recently listed snakebite envenoming as a Neglected Tropical Disease, proposing strategies to significantly reduce the global burden of this complex pathology by 2030. In this context, effective adjuvant treatments to complement conventional antivenom therapy based on inhibitory molecules for specific venom toxins have gained renewed interest. Varespladib (LY315920) is a synthetic molecule clinically tested to block inflammatory cascades of several diseases associated with elevated levels of secreted phospholipase A2 (sPLA2). Most recently, Varespladib was tested against several whole snake venoms and isolated PLA2 toxins, demonstrating potent inhibitory activity. Herein, we describe the first structural and functional study of the complex between Varespladib and a PLA2-like snake venom toxin (MjTX-II). In vitro and in vivo experiments showed this compound’s capacity to inhibit the cytotoxic and myotoxic effects of MjTX-II from the medically important South American snake, Bothrops moojeni. Crystallographic and bioinformatics analyses revealed interactions of Varespladib with two specific regions of the toxin, suggesting inhibition occurs by physical blockage of its allosteric activation, preventing the alignment of its functional sites and, consequently, impairing its ability to disrupt membranes. Furthermore, based on the analysis of several crystallographic structures, a distinction between toxin activators and inhibitors is proposed. |
id |
UNSP_5d69b5d3ff31e3f945809373d13e082e |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/198181 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920)The World Health Organization recently listed snakebite envenoming as a Neglected Tropical Disease, proposing strategies to significantly reduce the global burden of this complex pathology by 2030. In this context, effective adjuvant treatments to complement conventional antivenom therapy based on inhibitory molecules for specific venom toxins have gained renewed interest. Varespladib (LY315920) is a synthetic molecule clinically tested to block inflammatory cascades of several diseases associated with elevated levels of secreted phospholipase A2 (sPLA2). Most recently, Varespladib was tested against several whole snake venoms and isolated PLA2 toxins, demonstrating potent inhibitory activity. Herein, we describe the first structural and functional study of the complex between Varespladib and a PLA2-like snake venom toxin (MjTX-II). In vitro and in vivo experiments showed this compound’s capacity to inhibit the cytotoxic and myotoxic effects of MjTX-II from the medically important South American snake, Bothrops moojeni. Crystallographic and bioinformatics analyses revealed interactions of Varespladib with two specific regions of the toxin, suggesting inhibition occurs by physical blockage of its allosteric activation, preventing the alignment of its functional sites and, consequently, impairing its ability to disrupt membranes. Furthermore, based on the analysis of several crystallographic structures, a distinction between toxin activators and inhibitors is proposed.Departamento de Física e Biofísica Instituto de Biociências Universidade Estadual Paulista (UNESP)Instituto Clodomiro Picado Facultad de Microbiología Universidad de Costa RicaCenter for Exploration and Travel Health California Academy of SciencesDepartamento de Física e Biofísica Instituto de Biociências Universidade Estadual Paulista (UNESP)Universidade Estadual Paulista (Unesp)Universidad de Costa RicaCalifornia Academy of SciencesSalvador, Guilherme H. M. [UNESP]Gomes, Antoniel A. S. [UNESP]Bryan-Quirós, WendyFernández, JuliánLewin, Matthew R.Gutiérrez, José MaríaLomonte, BrunoFontes, Marcos R. M. [UNESP]2020-12-12T01:05:49Z2020-12-12T01:05:49Z2019-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1038/s41598-019-53755-5Scientific Reports, v. 9, n. 1, 2019.2045-2322http://hdl.handle.net/11449/19818110.1038/s41598-019-53755-52-s2.0-85075347831Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengScientific Reportsinfo:eu-repo/semantics/openAccess2021-10-23T09:48:54Zoai:repositorio.unesp.br:11449/198181Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T21:30:02.680897Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
title |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
spellingShingle |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) Salvador, Guilherme H. M. [UNESP] |
title_short |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
title_full |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
title_fullStr |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
title_full_unstemmed |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
title_sort |
Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
author |
Salvador, Guilherme H. M. [UNESP] |
author_facet |
Salvador, Guilherme H. M. [UNESP] Gomes, Antoniel A. S. [UNESP] Bryan-Quirós, Wendy Fernández, Julián Lewin, Matthew R. Gutiérrez, José María Lomonte, Bruno Fontes, Marcos R. M. [UNESP] |
author_role |
author |
author2 |
Gomes, Antoniel A. S. [UNESP] Bryan-Quirós, Wendy Fernández, Julián Lewin, Matthew R. Gutiérrez, José María Lomonte, Bruno Fontes, Marcos R. M. [UNESP] |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Universidad de Costa Rica California Academy of Sciences |
dc.contributor.author.fl_str_mv |
Salvador, Guilherme H. M. [UNESP] Gomes, Antoniel A. S. [UNESP] Bryan-Quirós, Wendy Fernández, Julián Lewin, Matthew R. Gutiérrez, José María Lomonte, Bruno Fontes, Marcos R. M. [UNESP] |
description |
The World Health Organization recently listed snakebite envenoming as a Neglected Tropical Disease, proposing strategies to significantly reduce the global burden of this complex pathology by 2030. In this context, effective adjuvant treatments to complement conventional antivenom therapy based on inhibitory molecules for specific venom toxins have gained renewed interest. Varespladib (LY315920) is a synthetic molecule clinically tested to block inflammatory cascades of several diseases associated with elevated levels of secreted phospholipase A2 (sPLA2). Most recently, Varespladib was tested against several whole snake venoms and isolated PLA2 toxins, demonstrating potent inhibitory activity. Herein, we describe the first structural and functional study of the complex between Varespladib and a PLA2-like snake venom toxin (MjTX-II). In vitro and in vivo experiments showed this compound’s capacity to inhibit the cytotoxic and myotoxic effects of MjTX-II from the medically important South American snake, Bothrops moojeni. Crystallographic and bioinformatics analyses revealed interactions of Varespladib with two specific regions of the toxin, suggesting inhibition occurs by physical blockage of its allosteric activation, preventing the alignment of its functional sites and, consequently, impairing its ability to disrupt membranes. Furthermore, based on the analysis of several crystallographic structures, a distinction between toxin activators and inhibitors is proposed. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-01 2020-12-12T01:05:49Z 2020-12-12T01:05:49Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1038/s41598-019-53755-5 Scientific Reports, v. 9, n. 1, 2019. 2045-2322 http://hdl.handle.net/11449/198181 10.1038/s41598-019-53755-5 2-s2.0-85075347831 |
url |
http://dx.doi.org/10.1038/s41598-019-53755-5 http://hdl.handle.net/11449/198181 |
identifier_str_mv |
Scientific Reports, v. 9, n. 1, 2019. 2045-2322 10.1038/s41598-019-53755-5 2-s2.0-85075347831 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Scientific Reports |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808129326626897920 |